Turnover—
EBIT margin—
Net result€78k
Working capital€-140k+35.9%
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Hearts & Science is 3.2% (average). The 2024 annual accounts show negative equity (€-140k) and a net result of €78k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone3.2%
Average
0%0,5%1,5%4%10%≥25%
Young company
+Higher-failure-rate region
+Annual accounts: weaker financial profile
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Financials
FY 2024
€-140k
equity
Turnover—
Net result€78kHealth13/100 · Critical
See full annual accounts
People & board
1 mandate
1
active director
SMART MINDSDirector
All directors & mandates Publicationslatest 23-03-2026
9
publications in the State Gazette2 directors appointed, 1 resigningAll publications & acts Network & structure
6
connected companiesSee network & structure
Connections
6 connected companiesParent · 5 subsidiaries · 1 location
Control→
Trust signals
3 signalsMore than 3 years active
Founded in 2023 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Company registry (CBE)
Crossroads BankActivities
Reclamebureaus73110Activiteiten van reclamebureaus73110Mediarepresentatie73120Mediarepresentatie73120
Primary activity highlighted.
Names & trade names
| Legal nameFR | Hearts & Science |
| Legal nameNL | Hearts & Science |
Registered office
Scheldestraat 122
1080 Sint-Jans-Molenbeek, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.